Please note that we charge an extra fee for prenatal analysis.
Prenatal Testing Is Given the Highest Priority at CENTOGENE
Learn more about our prenatal genetic testing options, which enable rapid and reliable identification of disease-causing mutations, even at the early stages of pregnancy.
Prenatal Testing and Diagnosis
Chooising the appropriate testing strategy is crucial in providing the best care for your patients.
This is why CENTOGENE offers a turnaround time of ten business days for most prenatal analyses (known variants, deletion/duplication analysis, single gene sequencing) and of less than 15 business days for Next Generation Sequencing (NGS) analyses (CentoXome®, CentoGenome® and CentoArray®). In addition, our medical experts are always available for your support before, during, and after the analysis.
Starting Material
- Chorionic villi
- Amniotic fluid
- Fetal DNA
- Cord blood (for late pregnancies) as possible material
You have the option to send us tubes with already cultivated cells. Alternatively, we offer CentoCulture®, our cell cultivation service.
Contact Us
Please always contact us prior to every prenatal sample sending to prevent transport delays and to allow us to give the analysis top priority. Please provide the following mandatory information :
- Logistics tracking number of sample shipment
- Requested analysis
- Physician's contact information
All prenatal cases are specifically assigned to our dedicated prenatal team who takes the utmost individual care.
Contact Details
Logistic and Communication Manager
+49 381 80113 663
logistics@centogene.com
For timely sample registration over the weekend, all prenatal samples must reach our laboratory no later than 3:30 p.m. CEST on Friday or 2:00 p.m. CEST on Saturday.
Resources
Downloads
Gene List Prenatal Testing
CENTOGENE’s prenatal gene list for CentoXome® and CentoGenome® analysis
Scientific Publications
A Novel Therapeutic Concept for Fabry Disease
Fabry disease is caused by mutations that affect the lysosomal enzyme α-galactosidase, but the pathophysiology of the disease remains to be completely understood. A recent study that was co-authored […]
Loading...
Large Patient Cohort Enables Insights into a Rare Disease
Farber disease (FD) is a severe disorder for which rarity has hampered a comprehensive understanding. A recent study on a large cohort of patients provides unprecedented novel insights into FD. The […]
Loading...
Successful Monitoring of Gaucher Disease
Biomarkers are key tools in establishing a diagnosis and monitoring rare disorders. The lipid metabolite Lyso-Gb1 has long been known as an excellent diagnostic biomarker. In a recent study, which […]
Loading...
Related Webinars
How Biomarkers Transform Genetic Diagnostics: A Success Story With Fabry Disease
Throughout the on demand CentoTalk, Dr. Tobias Boettcher provides an overview of how biomarkers play an essential role in early diagnosis, prediction, and therapeutic monitoring for Fabry disease […]
Loading...
Multiomics and Biomarkers in Rare Diseases Supporting Development and Commercialization of Orphan Drugs
Watch our webinar to learn about innovative methods to tackle the challenges of orphan drugs in early stage development, clinical trial enrollment, and market development.
Loading...
Biomarcadores: acelerando diagnósticos y guiando tratamientos
Mira nuestro webinar sobre biomarcadores, donde discutiremos un enfoque multiómico, que combina información sobre la genómica, la proteómica y la metabolómica, para acelerar la interpretación de los […]
Loading...
Get in Touch With Our Customer Support
Our consultation service is available in several languages.
+49 (0) 381 80 113 - 416
Mon. – Fri. 7 a.m. – 6:30 p.m. CET
Sat. 8 a.m. – 12 p.m. CET
PLEASE NOTE
For timely sample registration over the weekend, all prenatal samples must reach our laboratory no later than 3:30 p.m. CEST on Friday or 2:00 p.m. CEST on Saturday.